Unresectable Solid Tumor Clinical Trials

17 clinical trials for Unresectable Solid Tumor across international registries, including 12 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• First-in-Human Trial of DS1025a in Participants With Advanced Solid Tumors — RECRUITING · PHASE1
• Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors — RECRUITING · PHASE1
• FORTRAS: A Study of MSK-TCR5 in People With Solid Tumor Cancers — RECRUITING · PHASE1
• Pemigatinib + Afatinib in Advanced Refractory Solid Tumors — RECRUITING · PHASE1
• A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors — RECRUITING · PHASE1
• A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation — RECRUITING · PHASE1
• A Dose Escalation and Expansion Study of [177Lu]Lu-SN201 in Participants With Advanced Cancer — RECRUITING · PHASE1
• First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer — RECRUITING · PHASE1
• A Beta-only IL-2 ImmunoTherapY Study — RECRUITING · PHASE1
• A Multicenter Study of Avapritinib Efficacy and Safety of Metastatic or Unresectable Gastrointestinal Stromal Tumors — RECRUITING
• Avapritinib in the Treatment of Unresectable or Recurrent Metastatic GIST Non-exon18 Mutations of PDGFRA — RECRUITING
• COLDFIRE-III Trial: Efficacy of Irreversible Electroporation and Stereotactic Body Radiotherapy for Perivascular and Peribiliary Colorectal Liver Metastases — RECRUITING · PHASE2
• A Study of IOV-5001 in Adults With Advanced Solid Tumors — NOT_YET_RECRUITING · PHASE1
• Palliative Spatially Fractionated (GRID) Radiotherapy Using Intensity Modulated Proton Therapy — ACTIVE_NOT_RECRUITING · NA
• CSB-321 Ph 1 in Immunotherapy for the Treatment of Cancer — NOT_YET_RECRUITING · PHASE1
• First-in-Human Study of RLY-5836 in Advanced Breast Cancer and Other Solid Tumors — COMPLETED · PHASE1
• A Study of RC118 in Patients With Locally Advanced Unresectable/Metastatic Solid Tumours — COMPLETED · PHASE1

Refine this search